Comprehensive GMP vaccine testing methods to support you throughout your vaccine development and production
As vaccine pipelines expand across mRNA, viral vector and protein-based platforms, regulatory expectations from the MHRA, FDA, and EMA continue to intensify demanding robust analytical evidence of quality, safety and efficacy at every development stage.
RSSL delivers comprehensive GMP analytical testing tailored to each modality: viral vector titre, purity and identity testing; mRNA integrity and lipid nanoparticle characterisation and protein therapeutic characterisation, potency and stability.
